JF
Jasmin Faizal
About Jasmin Faizal
Data last updated:
Jasmin Faizal is a Director at Integron Pharma Private Limited (since 2011), Director at Waymed Proximus Private Limited (since 2025) and Managing Director at Df Endoklinic.In Private Limited (since 2023). The companies operate in Pharma and Paper. The largest current company by reported revenue is Integron Pharma Private Limited at ₹8.36 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Integron Pharma Private Limited U51397KL2007PTC020904 | Director | 07 Jan 2011 | 2007 | ₹8.36 Cr (FY 2024) | Active |
| Waymed Proximus Private Limited U21000KL2024PTC089688 | Director | 03 Feb 2025 | 2024 | Active | |
| Df Endoklinic.In Private Limited U86100KL2023PTC081302 | Managing Director | 08 May 2023 | 2023 | Active |
Board colleagues of Jasmin Faizal
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jasmin Faizal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jasmin Faizal
Jasmin Faizal currently holds 3 directorships: Integron Pharma Private Limited (Director, since 07 Jan 2011, revenue ₹8.36 Cr (FY 2024)); Waymed Proximus Private Limited (Director, since 03 Feb 2025); Df Endoklinic.In Private Limited (Managing Director, since 08 May 2023).
Jasmin Faizal was first appointed on 07 Jan 2011 as Director at Integron Pharma Private Limited. The most recent appointment on record is 03 Feb 2025 at Waymed Proximus Private Limited.
The current boards of Jasmin Faizal's companies include Jaya Sree Narayanan (Integron Pharma Private Limited), Karuvarath Shanoj (Integron Pharma Private Limited), Kizhakkapedika Rijo Varghese (Integron Pharma Private Limited), Prasad Sivadas (Integron Pharma Private Limited), Saji Kuzhi Chalil (Integron Pharma Private Limited), Thaniyan Salim (Integron Pharma Private Limited), among others.